Actinogen Medical

Industry Lists

Actinogen Medical Limited (ACW, formerly Actinogen Limited) is an ASX-listed biotechnology company developing innovative treatments for Alzheimer's disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases, like Type 2 diabetes. It focusses on the development of Xanamem, a novel treatment for Alzheimer's disease and the cognitive deficiency associated with other neurological and metabolic diseases within Australia.

Contact Details

Suite 901, Level 9, 109 Pitt St, SYDNEY NSW 2000

02 8964 7401

info@actinogen.com.au

www.actinogen.com.au

Lists and Charts

Share price

Closing price for the last 90 trading days

View ASX Chart

Total Shareholder Return as at 30/08/24

Rank	Company	1 yr	5 yr
148^th	Actinogen Medical	82%	43%

View Full List

1746 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Revenue

Rank		Company	Revenue
867^th		Actinogen Medical	$4.8m

View Full List

1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Share Transactions

05/06/24

$8k Issued

Malcolm McComas

05/06/24

$4k Issued

Malcolm McComas

05/06/24

$0 Issued

George Morstyn

Total value as at the date of the transaction

Company Activity

	NEWS: Tagged in Coking coal elbows antimony sideways to take centre stage	30 Aug 2024
	NEWS: Tagged in New money sends InteliCare share price flying	28 Jun 2024
	NEW ROLE: Dana Hilt,	04 Sep 2023
	NEW ROLE: Paul Rolan,	03 Jan 2023
	NEW ROLE: Steven Gourlay, Chief Executive Officer, Managing Director	13 Apr 2022
	NEW ROLE: Jeff Carter,	01 Mar 2022
	NEW ROLE: Tamara Miller,	01 Mar 2022
	REMUNERATION UPDATE: Malcolm McComas, Non-Executive Director	03 Nov 2020
	REMUNERATION UPDATE: Bill Ketelbey, Chief Executive Officer, Managing Director	03 Nov 2020